Civic Intelligence

Path Vaccine Solutions

990 • Fiscal year 2015 • EIN 83-0431851

Jan 01, 2015 to Dec 31, 2015 • Filed on Nov 11, 2016

Organization ProfileWWW.PATH.ORG
2201 Westlake Avenue No 200Seattle, WA 98121

(206) 285-3500

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

12th percentile

0.03x

Higher debt load relative to assets than 12% of similar nonprofits.

2015 filings • 501(c)3 • $100M-$250M nonprofits • Source year 2015

Liabilities / Revenue

10th percentile

0.09x

Higher debt load relative to revenue than 10% of similar nonprofits.

2015 filings • 501(c)3 • $100M-$250M nonprofits • Source year 2015

Net Margin

79th percentile

18%

Higher net margin than 79% of similar nonprofits.

2015 filings • 501(c)3 • $100M-$250M nonprofits • Source year 2015

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2015

Asset Growth

48th percentile

1.2%

Faster asset growth than 48% of similar nonprofits.

2015 filings • 501(c)3 • $100M-$250M nonprofits • Annualized from 2014 to 2015

Revenue Growth

96th percentile

89%

Faster revenue growth than 96% of similar nonprofits.

2015 filings • 501(c)3 • $100M-$250M nonprofits • Annualized from 2014 to 2015

Balance Sheet
Liabilities / Assets12th percentile

Assets

Up

$150,830,465

Up $1,785,915 (+1.2%) from 2014

Net Assets

Up

$146,770,618

Up $8,004,376 (+5.8%) from 2014

Liabilities

Down

$4,059,847

Down $6,218,461 (-61%) from 2014

Revenue And Expenses
Liabilities / Revenue10th percentileNet Margin79th percentile

Revenue

Up

$46,734,872

Up $21,963,118 (+89%) from 2014

Expenses

Down

$38,397,069

Down $8,771,958 (-19%) from 2014

Net Income

Up

$8,337,803

Up $30,735,076 (+137%) from 2014

Historical Trend

Balance Sheet Trend

Asset Growth48th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$200M$150M$100M$50M$0Assets 2010: $151,102,797Liabilities 2010: $4,781,234Net Assets 2010: $146,321,5632010Assets 2011: $133,507,981Liabilities 2011: $6,691,219Net Assets 2011: $126,816,7622011Assets 2012: $142,045,531Liabilities 2012: $2,850,743Net Assets 2012: $139,194,7882012Assets 2013: $166,859,076Liabilities 2013: $6,024,155Net Assets 2013: $160,834,9212013Assets 2014: $149,044,550Liabilities 2014: $10,278,308Net Assets 2014: $138,766,2422014Assets 2015: $150,830,465Liabilities 2015: $4,059,847Net Assets 2015: $146,770,6182015Assets 2016: $107,465,507Liabilities 2016: $15,803,401Net Assets 2016: $91,662,1062016Assets 2017: $66,391,789Liabilities 2017: $14,042,965Net Assets 2017: $52,348,8242017Assets 2018: $38,472,788Liabilities 2018: $37,875,254Net Assets 2018: $597,5342018Assets 2019: $38,989,543Liabilities 2019: $36,842,677Net Assets 2019: $2,146,8662019

Highlighted filing

2015

Assets$150,830,465
Liabilities$4,059,847
Net Assets$146,770,618
Open 2015 Filing

Operations Trend

Revenue Growth96th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$100M$50M$0-$50MExpenses 2010: $35,920,9952010Revenue 2011: $18,181,537Expenses 2011: $37,226,565Net Income 2011: -$19,045,0282011Revenue 2012: $52,130,143Expenses 2012: $40,164,028Net Income 2012: $11,966,1152012Revenue 2013: $59,399,215Expenses 2013: $37,490,390Net Income 2013: $21,908,8252013Revenue 2014: $24,771,754Expenses 2014: $47,169,027Net Income 2014: -$22,397,2732014Revenue 2015: $46,734,872Expenses 2015: $38,397,069Net Income 2015: $8,337,8032015Revenue 2016: $5,990,503Expenses 2016: $42,072,773Net Income 2016: -$36,082,2702016Revenue 2017: $7,108,916Expenses 2017: $43,734,346Net Income 2017: -$36,625,4302017Revenue 2018: $35,807,318Expenses 2018: $35,391,575Net Income 2018: $415,7432018Revenue 2019: $10,961,263Expenses 2019: $9,746,391Net Income 2019: $1,214,8722019

Highlighted filing

2015

Revenue$46,734,872
Expenses$38,397,069
Net Income$8,337,803
Open 2015 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2015 to Dec 31, 2015
Signed
Nov 11, 2016
Return Version
2015v2.1
Gross Receipts
$66,233,669
Mission and Program Overview

Mission

The mission of path vaccine solutions (pvs) is to improve the health of children in low-income countries by accelerating the development of vaccines that will be effective and affordable for those who need them most. From initial discovery through clinical trials, pvs works with commercial partners, such as vaccine manufacturers and biotechnology firms, and nonprofit partners, such as universities and research institutions, to shorten the timeline for vaccine development.pvs works with partners to develop new vaccines by providing funding and expertise in preclinical development, manufacturing, and clinical development, with a focus on low-resource countries. In return, partners agree to terms that help ensure the resulting products are affordable and available in developing countries.

SEE PART III, LINE 1.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$72,983,433$73,413,349▲ $429,916
Pledges and Grants Receivable$60,119,568$59,593,963▼ $525,605
Savings and Temporary Cash Investments$15,650,996$17,554,485▲ $1,903,489
Accounts Receivable$126,845$168,331▲ $41,486
Land, Buildings, and Equipment, Net$163,708$100,337▼ $63,371
Total Assets$149,044,550$150,830,465▲ $1,785,915
Liabilities
Accounts Payable and Accrued Expenses$10,278,308$4,059,847▼ $6,218,461
Total Liabilities$10,278,308$4,059,847▼ $6,218,461
Net Assets / Fund Balance
Temporarily Rstr Net Assets$138,728,660$146,752,511▲ $8,023,851
Unrestricted Net Assets$37,582$18,107▼ $19,475
Total Net Assets Fund Balance$138,766,242$146,770,618▲ $8,004,376
Total Liabilities and Net Assets / Fund Balance$149,044,550$150,830,465▲ $1,785,915

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$100,337$127,204$227,541
Compensation and Service Providers
Top Officer PayScore unavailable

Board Members and Trustees

NameTitle
Stephen B DavisChair and President
Penny HeatonVice Chair
Amie E BatsonDirector
Chris KarpDirector
David C KaslowDirector
Daniel LasterDirector / General Counsel
David a AlliSecretary
Olivia D PoliusTreasurer

Highest Paid Contractors

ContractorServicesLocationCompensation
Northern TrustAsset Management50 S LASALLE ST, Chicago, IL 60675$121,287
Revenue and Support

Revenue Composition

Contributions and Grants
$45,999,268
Program Service Revenue
$0
Investment Income
$733,017
Other Revenue
$2,587
All Other Contributions
$45,914,986
Change in Net Assets
$8,337,803
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$28,397,080
Other Expenses$9,999,989
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$23,229,760--$23,229,760
Foreign Grants$5,167,320--$5,167,320
Travel$1,501,413--$1,501,413
Fees for Services Other$554,844--$554,844
Office Expenses$278,113--$278,113
Insurance$146,473--$146,473
Conferences and Meetings$129,863--$129,863
Fees for Service Investment Mgmnt Fees$121,287--$121,287
Other Expenses$57,545--$57,545
Information Technology$11,495--$11,495
Advertising$6,285--$6,285
Royalties$5,000--$5,000
Fees for Services Legal$4,678--$4,678
All Other Expenses$1,867--$1,867
Total Functional Expenses$38,397,069$0$0$38,397,069
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
PathSeattle, WA501(c)(3)Product Development$14,137,772
Affinivax IncLexington, MAN/aProduct Development$3,269,285
Walter Reed Army Institute of ResearchSilver Spring, MDGovProduct Development$1,031,865
BOSTON CHILDREN'S HOSPITALBoston, MA501(c)(3)Product Development$913,516
Johns Hopkins UniversityBaltimore, MD501(c)(3)Product Development$570,533
Family Health International 360Durham, NC501(c)(3)Product Development$514,512
Novavax IncRockville, MDN/aProduct Development$483,726
University of Maryland BaltimoreBaltimore, MD501(c)(3)Product Development$400,000
Fina Biosolutions LLCRockville, MDN/aProduct Development$351,245
University of Alabama at BirminghamBirmingham, AL501(c)(3)Product Development$250,000
United States Naval Medical Research CenterSilver Spring, MDGovProduct Development$212,567
Jhu Bloomberg School of Public HealthBaltimore, MD501(c)(3)Product Development$174,680
Kansas State UniversityManhattan, KS501(c)(3)Product Development$160,000
University of FloridaGainesville, FL501(c)(3)Product Development$152,772
University of Maryland Sch of Med Inst for Genome SciencesBaltimore, MD501(c)(3)Product Development$150,934
University of Maryland School of Medicine Center for Vaccine DevBaltimore, MD501(c)(3)Product Development$141,038
Harvard University School of Public HealthBoston, MA501(c)(3)Product Development$127,753
Tulane Educational FundNew Orleans, LA501(c)(3)Product Development$83,465
Lankenau Institute for Medical ResearchWynnewood, PA501(c)(3)Product Development$58,334
Washington University in St LouisSt Louis, MO501(c)(3)Product Development$33,717
Emmes CorporationRockville, MDN/aProduct Development$21,013
Oklahoma State UniversityStillwater, OK501(c)(3)Product Development$-17
Washington University in St LouisSt Louis, MO501(c)(3)Product Development$-271
Advanced Bioscience Laboratories IncRockville, MDN/aProduct Development$-8,680

International Summary

Offices
0
Employees
11
Spending
$7,815,896

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
Yes

International Activities

RegionActivityServicesOfficesEmployeesSpending
South AsiaGrantmaking-00$3,125,936
EuropeGrantmakingProduct Development00$1,255,350
Sub-saharan AfricaProgram Services-01$1,173,248
South AsiaProgram Services-010$761,932
East Asia and the PacificGrantmakingProduct Development00$561,337
EuropeProgram ServicesProduct Development00$519,205
Sub-saharan AfricaGrantmaking-00$224,697
East Asia and the PacificProgram ServicesProduct Development00$181,906
South AmericaProgram ServicesProduct Development00$7,281
North AmericaProgram ServicesProduct Development00$4,839
Central America and the CaribbeanProgram ServicesProduct Development00$165
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11

“The form 990 was prepared by an outside accounting firm (gelman, rosenberg & freedman) using information provided by path accounting services staff. Path senior management reviewed the draft form. A copy of the draft was sent to path's board of directors for comment. After the comment period, the chief financial officer signed and filed the return.”

Form 990, Part VI, Section B, Line 12C

“Pvs has policies and procedures to address conflicts of interest. Path management and all staff above a designated level in the organization must complete a conflict of interest disclosure form each year. All forms are reviewed and kept on file. A conflict management plan is developed for any employee with a significant actual or perceived conflict of interest. Path also has a well-defined procedure for identifying and reporting actual and potential conflicts of interest among board members. New board members are asked to complete a conflict of interest disclosure form within 30 days of joining the board and to complete a new form annually thereafter. In addition, members are reminded to report any new issues that arise outside of the annual disclosure period. The disclosure forms are reviewed by path's general counsel, and, if any actual or potential conflicts are identified, general counsel makes a recommendation to the chair of the governance committee and the chair of the board for a management plan to properly manage any conflicts. A formal management plan is then agreed upon with the board member, and the entire board of directors is informed at the next regularly scheduled board meeting.”

Form 990, Part VI, Section C, Line 19

“Pvs's governing documents, conflict of interest policy, and financial statements are available to the public upon request; most documents are also available online.”

Filing and Contact Details

Filer

Filer Name
Path Vaccine Solutions
EIN
83-0431851
Phone
2062853500
Address
2201 WESTLAKE AVENUE NO 200, SEATTLE, WA 98121

Signing Officer

Name
Olivia D Polius
Title
Chief Financial Officer
Phone
2062853500
Signed
2016-11-11
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Olivia D Polius
Formed
2006
Legal Domicile
Wa
Voting Board Members
7
Independent Board Members
2
Employees
0
Volunteers
0

Preparer

Firm
Gelman Rosenberg & Freedman
Address
4550 MONTGOMERY AVE SUITE 650N, BETHESDA, MD 20814-2930
Phone
3019519090
Supplemental Narrative

Additional Explanations

FORM 990, PART XI, LINE 9:

“From time to time, unspent award funds (or unused obligations) may be returned to a funder for a variety of reasons including, but not limited to, early termination of a project by a funder, or a reduction in funds required to accomplish a project's scope of work. -85,565.”

Raw XML AppendixShowing 400 of 953 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt010278308
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt04059847
IRS990/AccountsReceivableGrp/BOYAmt0126845
IRS990/AccountsReceivableGrp/EOYAmt0168331
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0SEE PART III, LINE 1.
IRS990/AdvertisingGrp/ProgramServicesAmt06285
IRS990/AdvertisingGrp/TotalAmt06285
IRS990/AllOtherContributionsAmt045914986
IRS990/AllOtherExpensesGrp/ProgramServicesAmt01867
IRS990/AllOtherExpensesGrp/TotalAmt01867
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0OLIVIA POLIUS CHIEF FINANCIAL OFFICER
IRS990/BooksInCareOfDetail/PhoneNum02062853500
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt02201 WESTLAKE AVE SUITE 200
IRS990/BooksInCareOfDetail/USAddress/CityNm0SEATTLE
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0WA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd098121
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt01
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt0129863
IRS990/ConferencesMeetingsGrp/TotalAmt0129863
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/ContractorCompensationGrp/CompensationAmt0121287
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt050 S LASALLE ST
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0CHICAGO
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0IL
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd060675
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0NORTHERN TRUST
IRS990/ContractorCompensationGrp/ServicesDesc0ASSET MANAGEMENT
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt045999268
IRS990/CYGrantsAndSimilarPaidAmt028397080
IRS990/CYInvestmentIncomeAmt0733017
IRS990/CYOtherExpensesAmt09999989
IRS990/CYOtherRevenueAmt02587
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt08337803
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt038397069
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt046734872
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0PVS WORKS TO PREVENT DEATH AND DISEASE CAUSED BY DIARRHEA, PNEUMONIA, INFLUENZA, RESPIRATORY SYNCYTIAL VIRUS, AND POLIO AMONG CHILDREN AROUND THE WORLD. WE ACCELERATE THE DEVELOPMENT OF SAFE, EFFICACIOUS, AND AFFORDABLE VACCINES IN PARTNERSHIP WITH PUBLIC AND PRIVATE GROUPS. IN 2015, PVS CONTINUED OUR FIGHT AGAINST DIARRHEAL DISEASE, THE SECOND LEADING CAUSE OF DEATH AMONG CHILDREN IN THE DEVELOPING WORLD. TO COMBAT ROTAVIRUS, A MAJOR CAUSE OF SEVERE DIARRHEA, WE PARTNERED WITH SERUM INSTITUTE OF INDIA PVT. LTD. (SIIPL) TO STUDY A VACCINE THAT MAY REMAIN STABLE AND POTENT EVEN DURING EXTENDED PERIODS WITHOUT REFRIGERATION, ENABLING WIDER USE IN REMOTE COMMUNITIES. WE COMPLETED ENROLLMENT FOR A PHASE 3 EFFICACY STUDY OF THE VACCINE (THE LARGEST EVER UNDERTAKEN AMONG CHILDREN IN INDIA) AND BEGAN A STUDY TO EXAMINE CLINICAL LOT CONSISTENCY AND POTENTIAL INTERFERENCE WITH OTHER ROUTINE VACCINES. FINALLY, ROTAVAC , AN INDIAN-MADE VACCINE DEVELOPED WITH PATH SUPPORT, REMAINED ON TRACK FOR INTRODUCTION IN INDIA'S PUBLIC SECTOR IN 2016.OUR EFFORTS TO COMBAT ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) AND SHIGELLA, IMPORTANT CAUSES OF BACTERIAL DIARRHEAL ILLNESS, HAVE RESULTED IN THE INITIATION AND CONTINUATION OF NUMEROUS CLINICAL TRIALS. IN 2015, WE BEGAN A CLINICAL STUDY OF ETVAX, AN INACTIVATED, WHOLE CELL VACCINE CANDIDATE AGAINST ETEC, AT ICDDR,B IN BANGLADESH. WE ALSO WORKED WITH THE US NAVAL MEDICAL RESEARCH CENTER TO EVALUATE THE PROTECTIVE EFFICACY OF AN ETEC VACCINE CANDIDATE. THE EVALUATION IDENTIFIED POSITIVE TRENDS IN PROTECTION. TO PROTECT AGAINST SHIGELLA, WE PARTNERED WITH THE WALTER REED ARMY INSTITUTE OF RESEARCH TO STUDY A LIVE ATTENUATED VACCINE CANDIDATE IN CHILDREN FIVE TO NINE YEARS OF AGE. RESULTS REVEALED THE VACCINE TO BE SAFE AND IMMUNOGENIC. OUR WORK TO ADVANCE THE DEVELOPMENT OF LOW-COST, PEDIATRIC VACCINE CANDIDATES AGAINST THE PNEUMOCOCCUS BACTERIUM-THE TOP CAUSE OF SEVERE CHILDHOOD PNEUMONIA-PROGRESSED IN 2015 WITH THE CONTINUATION OF PHASE 1 AND 2 TRIALS IN AFRICA. IN THE GAMBIA, WE ARE EVALUATING A DECAVALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV-10) CANDIDATE, MANUFACTURED BY SIIPL. THE PCV-10 CANDIDATE IS DESIGNED TO BE AFFORDABLE AND FOCUSES ON THE TEN SEROTYPES CAUSING THE MOST CASES OF INVASIVE PNEUMOCOCCAL DISEASE IN AFRICA AND ASIA, WHERE MOST PNEUMOCOCCAL DEATHS OCCUR. IN KENYA, WE ARE STUDYING A PNEUMOCOCCAL WHOLE CELL VACCINE CANDIDATE DEVELOPED IN PARTNERSHIP WITH BOSTON CHILDREN'S HOSPITAL THAT HAS THE POTENTIAL TO PROVIDE BROAD PROTECTION ACROSS THE MANY SEROTYPES OF PNEUMOCOCCUS AT A LOW PRICE. BOTH VACCINE CANDIDATES ARE DESIGNED TO MEET COST AND DISEASE COVERAGE NEEDS IN LOW-RESOURCE SETTINGS AND COULD HELP FREE UP DONOR FUNDS FOR OTHER GLOBAL HEALTH PRIORITIES IF SUCCESSFUL.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt038397069
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt04678
IRS990/FeesForServicesLegalGrp/TotalAmt04678
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0554844
IRS990/FeesForServicesOtherGrp/TotalAmt0554844
IRS990/FeesForSrvcInvstMgmntFeesGrp/ProgramServicesAmt0121287
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt0121287
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt05167320
IRS990/ForeignGrantsGrp/TotalAmt05167320
IRS990/ForeignOfficeInd01
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt039.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt239.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt339.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt439.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt539.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt60.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt720.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt720.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt059038
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt246727
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt330937
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt439328
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt558018
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt730665
IRS990/Form990PartVIISectionAGrp/PersonNm0STEPHEN B DAVIS
IRS990/Form990PartVIISectionAGrp/PersonNm1PENNY HEATON
IRS990/Form990PartVIISectionAGrp/PersonNm2OLIVIA D POLIUS
IRS990/Form990PartVIISectionAGrp/PersonNm3AMIE E BATSON
IRS990/Form990PartVIISectionAGrp/PersonNm4DANIEL LASTER
IRS990/Form990PartVIISectionAGrp/PersonNm5DAVID C KASLOW
IRS990/Form990PartVIISectionAGrp/PersonNm6CHRIS KARP
IRS990/Form990PartVIISectionAGrp/PersonNm7DAVID A ALLI
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt0607729
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt2264997
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt3283722
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt4268812
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt5316540
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt7160737
IRS990/Form990PartVIISectionAGrp/TitleTxt0CHAIR AND PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1VICE CHAIR
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR / GENERAL COUNSEL
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7SECRETARY
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02006
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt019037
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GrantAmt028397080
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt023229760
IRS990/GrantsToDomesticOrgsGrp/TotalAmt023229760
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt019517834
IRS990/GrossReceiptsAmt066233669
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt02
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/ProgramServicesAmt011495
IRS990/InformationTechnologyGrp/TotalAmt011495
IRS990/InsuranceGrp/ProgramServicesAmt0146473
IRS990/InsuranceGrp/TotalAmt0146473
IRS990/InvestmentIncomeGrp/ExclusionAmt0713980
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0713980
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt072983433
IRS990/InvestmentsPubTradedSecGrp/EOYAmt073413349
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0127204
IRS990/LandBldgEquipBasisNetGrp/BOYAmt0163708
IRS990/LandBldgEquipBasisNetGrp/EOYAmt0100337
IRS990/LandBldgEquipCostOrOtherBssAmt0227541
IRS990/LegalDomicileStateCd0WA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt019498797
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE MISSION OF PATH VACCINE SOLUTIONS (PVS) IS TO IMPROVE THE HEALTH OF CHILDREN IN LOW-INCOME COUNTRIES BY ACCELERATING THE DEVELOPMENT OF VACCINES THAT WILL BE EFFECTIVE AND AFFORDABLE FOR THOSE WHO NEED THEM MOST. FROM INITIAL DISCOVERY THROUGH CLINICAL TRIALS, PVS WORKS WITH COMMERCIAL PARTNERS, SUCH AS VACCINE MANUFACTURERS AND BIOTECHNOLOGY FIRMS, AND NONPROFIT PARTNERS, SUCH AS UNIVERSITIES AND RESEARCH INSTITUTIONS, TO SHORTEN THE TIMELINE FOR VACCINE DEVELOPMENT.PVS WORKS WITH PARTNERS TO DEVELOP NEW VACCINES BY PROVIDING FUNDING AND EXPERTISE IN PRECLINICAL DEVELOPMENT, MANUFACTURING, AND CLINICAL DEVELOPMENT, WITH A FOCUS ON LOW-RESOURCE COUNTRIES. IN RETURN, PARTNERS AGREE TO TERMS THAT HELP ENSURE THE RESULTING PRODUCTS ARE AFFORDABLE AND AVAILABLE IN DEVELOPING COUNTRIES.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt0138766242
IRS990/NetAssetsOrFundBalancesEOYAmt0146770618
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt019037
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt019037
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0-247862
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ProgramServicesAmt0278113
IRS990/OfficeExpensesGrp/TotalAmt0278113
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt0-85565
IRS990/OtherExpensesGrp/Desc0SUBCONTRACTORS
IRS990/OtherExpensesGrp/Desc1EQUIPMENT R&M
IRS990/OtherExpensesGrp/Desc2LAB SUPPLIES
IRS990/OtherExpensesGrp/Desc3STORAGE
IRS990/OtherExpensesGrp/ProgramServicesAmt06968234
IRS990/OtherExpensesGrp/ProgramServicesAmt1108073
IRS990/OtherExpensesGrp/ProgramServicesAmt2104819
IRS990/OtherExpensesGrp/ProgramServicesAmt357545
IRS990/OtherExpensesGrp/TotalAmt06968234
IRS990/OtherExpensesGrp/TotalAmt1108073
IRS990/OtherExpensesGrp/TotalAmt2104819
IRS990/OtherExpensesGrp/TotalAmt357545
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/BusinessCd1900099
IRS990/OtherRevenueMiscGrp/Desc0OTHER REIMBURSEMENTS
IRS990/OtherRevenueMiscGrp/Desc1MISCELLANEOUS
IRS990/OtherRevenueMiscGrp/ExclusionAmt02565
IRS990/OtherRevenueMiscGrp/ExclusionAmt122
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt02565
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt122
IRS990/OtherRevenueTotalAmt02587
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt060119568
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt059593963
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0OLIVIA D POLIUS
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt024448784
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt036562862
IRS990/PYInvestmentIncomeAmt0315733
IRS990/PYOtherExpensesAmt010606165
IRS990/PYOtherRevenueAmt07237
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-22397273
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt047169027
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt024771754
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt08337803
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/RelatedOrganizationsAmt084282
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RoyaltiesGrp/ProgramServicesAmt05000
IRS990/RoyaltiesGrp/TotalAmt05000
IRS990/SavingsAndTempCashInvstGrp/BOYAmt015650996
IRS990/SavingsAndTempCashInvstGrp/EOYAmt017554485
IRS990ScheduleA/Form990SchASupportingOrgGrp/Contribution35ControlledInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionControllerInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionFamilyInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ControlledDisqualifiedPrsnInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnControllIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnOwnrIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ExcessBusinessHoldingsRulesInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ListedByNameGoverningDocInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/LoanDisqualifiedPersonInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/OrganizationChangeSuprtOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/PaymentSubstantialContribtrInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgNotOrganizedUSInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgSectionC456Ind00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportNonSupportedOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SuprtOrgNoIRSDeterminationInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/OperateBenefitNonSuprtOrgInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/PowerAppointMajorityDirTrstInd01
IRS990ScheduleA/OtherSupportSumAmt00
IRS990ScheduleA/SupportedOrganizationsCnt01
IRS990ScheduleA/SupportedOrganizationsTotalCnt01
IRS990ScheduleA/SupportedOrgInformationGrp/EIN0911157127
IRS990ScheduleA/SupportedOrgInformationGrp/GoverningDocumentListedInd01
IRS990ScheduleA/SupportedOrgInformationGrp/OrganizationTypeCd07
IRS990ScheduleA/SupportedOrgInformationGrp/OtherSupportAmt00
IRS990ScheduleA/SupportedOrgInformationGrp/SupportAmt038397069
IRS990ScheduleA/SupportedOrgInformationGrp/SupportedOrganizationName/BusinessNameLine1Txt0PATH
IRS990ScheduleA/SupportingOrganization509a3Ind0X
IRS990ScheduleA/SupportingOrgType1Ind0X
IRS990ScheduleA/SupportSumAmt038397069
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/EquipmentGrp/BookValueAmt0100337
IRS990ScheduleD/EquipmentGrp/DepreciationAmt0127204
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt0227541
IRS990ScheduleD/TotalBookValueLandBuildingsAmt0100337
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt20
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt30
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt40
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt50
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt60
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt710
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt80
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt91
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt100
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt20
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt30
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt40
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt50
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt60
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt70
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt80
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt90
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt100
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt0165
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt1181906
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt2561337
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt3519205
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt41255350
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt54839
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt67281
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt7761932
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt83125936
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt91173248
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt10224697
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0CENTRAL AMERICA AND THE CARIBBEAN
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt1EAST ASIA AND THE PACIFIC
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt2EAST ASIA AND THE PACIFIC
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt3EUROPE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt4EUROPE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt5NORTH AMERICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt6SOUTH AMERICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt7SOUTH ASIA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt8SOUTH ASIA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt9SUB-SAHARAN AFRICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt10SUB-SAHARAN AFRICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt0PRODUCT DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt1PRODUCT DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt2PRODUCT DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt3PRODUCT DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt4PRODUCT DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt5PRODUCT DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt6PRODUCT DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt1PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt2GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt3PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt4GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt5PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt6PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt7PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt8GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt9PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt10GRANTMAKING
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt04523881
IRS990ScheduleF/ContinutationTotalEmployeeCnt01
IRS990ScheduleF/ContinutationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt015000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt120000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt260000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt374235
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt474902
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt5120452
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt6145781
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt7150000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt8209697
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt9275000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt10296686
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt11350764
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt12440000

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2015 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$150,830,465
Liabilities
$4,059,847
Net assets
$146,770,618
Revenue
$46,734,872
Expenses
$38,397,069
Net income
$8,337,803
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$39.0$36.8$2.15$11.0$9.75$1.21
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$38.5$37.9$0.60$35.8$35.4$0.42
2017Facts available. Structured filing facts are available, but richer extracted sections are limited.$66.4$14.0$52.3$7.11$43.7$36.6
2016Facts available. Structured filing facts are available, but richer extracted sections are limited.$107$15.8$91.7$5.99$42.1$36.1
2015Detailed filing. Detailed filing data is available for this year.$151$4.06$147$46.7$38.4$8.34
2014Detailed filing. Detailed filing data is available for this year.$149$10.3$139$24.8$47.2$22.4
2013Detailed filing. Detailed filing data is available for this year.$167$6.02$161$59.4$37.5$21.9
2012Summary only. Only limited summary data is available for this year.$142$2.85$139$52.1$40.2$12.0
2011Summary only. Only limited summary data is available for this year.$134$6.69$127$18.2$37.2$19.0
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$151$4.78$146$35.9